Literature DB >> 30563586

Atorvastatin: A Review of Analytical Methods for Pharmaceutical Quality Control and Monitoring.

Ana Carolina Kogawa1, Ana Elisa Della Torre Pires2, Hérida Regina Nunes Salgado1.   

Abstract

Background: Atorvastatin, a lipid-regulating drug, was the best-selling drug in the world in the early 2000s. Thus, monitoring of this drug is important because it is accessible to a large portion of the population. In addition, its quality control is fundamental to provide quality medicines. Method of analysis can be the first step in the rational use of pharmaceuticals. Objective/
Methods: In this context, a critical review of analytical methods present in the literature and official compendia for the pharmaceutical quality control of atorvastatin was made.
Results: Among the analytical methods most used in the evaluation of atorvastatin, HPLC is highlighted, followed by HPLC coupled to MS, and spectrophotometry in UV. Tablets are the most studied pharmaceutical samples, and plasma is the most studied biological matrix. In the literature, studies with atorvastatin-based pharmaceutical products are more common than biological materials. Acetonitrile is the organic solvent most commonly used in the methods surveyed to evaluate atorvastatin. Conclusions: Currently, awareness of the impact that the analytical choice has on the health of the operator and the environment is growing. Therefore, the suitability of existing methods for the determination of atorvastatin can be made to adhere to the current analytical chemistry. In this way, the analytical, environmental, and human consciousness will remain united. Highlights: Although the literature shows interesting methods from an economic and environmental point of view, such as UV, Vis miniaturized, and TLC, they can still be improved to meet the requirements of the current sustainable analytical chemistry.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30563586     DOI: 10.5740/jaoacint.18-0200

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  7 in total

1.  Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats.

Authors:  Mingyu Cui; Fengmei Zhu; Yifeng Yin; Yue Sui; Xueying Yan; Tingting Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-12-02       Impact factor: 2.441

2.  Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression.

Authors:  Jiayi Xiang; Huifang Zhang; Xingcheng Zhou; Dan Wang; Rongyu Chen; Wanlin Tan; Luqun Liang; Mingjun Shi; Fan Zhang; Ying Xiao; Yuxia Zhou; Yuanyuan Wang; Bing Guo
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

3.  Aged green tea reduces high-fat diet-induced fat accumulation and inflammation via activating the AMP-activated protein kinase signaling pathway.

Authors:  Ruohong Chen; Xingfei Lai; Limin Xiang; Qiuhua Li; Lingli Sun; Zhaoxiang Lai; Zhigang Li; Wenji Zhang; Shuai Wen; Junxi Cao; Shili Sun
Journal:  Food Nutr Res       Date:  2022-03-10       Impact factor: 3.894

4.  Do Biobank Recall Studies Matter? Long-Term Follow-Up of Research Participants With Familial Hypercholesterolemia.

Authors:  Miriam Nurm; Anu Reigo; Margit Nõukas; Liis Leitsalu; Tiit Nikopensius; Marili Palover; Tarmo Annilo; Maris Alver; Aet Saar; Toomas Marandi; Tiia Ainla; Andres Metspalu; Tõnu Esko; Neeme Tõnisson
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

5.  Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.

Authors:  Lijie Wang; Xiaoqin Tang
Journal:  Comput Math Methods Med       Date:  2022-07-18       Impact factor: 2.809

6.  Quality assessment of different brands of atorvastatin tablets available in Riyadh, Saudi Arabia.

Authors:  Ali AlMuhsin; Abdul Ahad; Yousef A Bin Jardan; Mohammad Raish; Ajaz Ahmad; Khalid M Alkharfy; Fahad I Al-Jenoobi
Journal:  BMC Pharmacol Toxicol       Date:  2022-09-13       Impact factor: 2.605

7.  Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction.

Authors:  You Yu; Lin Wang; Xu Zhu; Ya-Fei Liu; Hai-Ying Ma
Journal:  World J Diabetes       Date:  2021-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.